Objective: To determine the comparison of its clinical utility and safety profile for visual evoked potential (VEP) monitoring during prone spine surgeries under total intravenous anesthesia (TIVA) versus balanced general anesthesia using the SightSaver™ visual stimulator. Methods: The protocol was designed as a pilot, single center, prospective, randomized and double-arm study. Subjects were randomized to receive either TIVA or balanced general anesthesia. Following induction and intubation, 8 electrodes were placed subcutaneously to collect VEP recordings. The SightSaver™ visual stimulator was placed on the subject's scalp before prone positioning. VEP waveforms were recorded every 30 minutes and assessed by a neurophysiologist throughout the length of surgery. Results: A total of 19 subjects were evaluated and VEP waveforms were successfully collected. TIVA group showed higher amplitude and lower latency than balanced anesthesia. Conclusions: Our data suggested that TIVA is associated with higher VEP amplitude and shorter latencies than balanced general anesthesia; therefore, TIVA could be the most efficient anesthesia regimen for VEP monitoring. Significance: The findings help better understand the effect of different anesthesia regimens on intra-operative visual evoked potential monitoring.
Introduction
Visual Evoked Potential (VEP) is the illustration of electrical activity recorded from sensors placed on the subject's scalp overlying the visual cortex in response to visual stimuli. Changes in this electroencephalographic signal are characterized by a waveform, where changes in latency, amplitude, and morphology could be associated with specific pathologies (Holy et al. , 2009 , Ota et al. , 2010 , Andersson et al. , 2012 , Chung et al. , 2012 , Kamio et al. , 2014 , Luo et al. , 2015 . There exists a variety of stimuli that can be used in awake subjects, the most common being checkboard pattern-reversal VEP (Andersson et al. , 2012) . However, in sedated or comatose subjects a stronger stimuli is required, typically using a bright flash (Andersson et al. , 2012) .
Unfortunately, VEPs have been difficult to consistently elicit response in the operating room (OR) environment using standard techniques. The inability to deliver stable visual stimuli and obtain an adequate VEP recording can be caused by technical interventions, effects of volatile anesthesia, or inappropriate visual stimuli (Chung et al. , 2012 , Kamio et al. , 2014 . Other physiological factors that reduce its clinical application are body temperature, blood pressure, hematocrit, pH balance, and O 2 saturation (Banoub et al. , 2003) . VEP is also less likely to be detected in subjects with prior severe visual impairment (Neuloh, 2010 , Kamio et al. , 2014 , Luo et al. , 2015 . Furthermore, surgical complications associated with loss of intraoperative VEP monitoring include epileptic seizure, burr hole drilling and bone milling, electrode detachment, use of certain intraoperative drugs such as sodium thiopental or midazolam, and other unidentifiable causes (Kamio et al. , 2014 , Luo et al. , 2015 . Loss of VEP monitoring may or may not be directly correlated to postoperative visual changes (Harding et al. , 1990 , Goto et al. , 2007 , Chung et al. , 2012 . Chung et al. asserted that changes in VEP waveform failed to indicate visual decline. (Chung et al. , 2012) . Therefore, due to controversial and conflicting reports, a consensus of the usefulness and feasibility of intraoperative VEP monitoring with acceptable outcomes and sensitivity remains inconclusive (Kodama et al. , 2010) .
Additionally, the anesthetic regimen used during surgery presumably has a strong influence on the stability of intraoperative VEP recording (Neuloh, 2010) . Total intravenous anesthesia (TIVA), volatile induction/maintenance anesthesia (VIMA), and balanced general anesthesia (combination of TIVA and VIMA) are the current anesthesia regimens used for spine surgeries. These regimens have been proven to offer an adequate level of anesthesia, hemodynamic stability, and safety profile (Watson et al. , 2000) . A few researchers describe TIVA as the anesthetic regimen with fewer effects on VEP monitoring, whereas VIMA decreases VEP accuracy with direct proportionality to the dosage received, increasing latency, and decreasing amplitude and reliability (Watson et al. , 2000 , Neuloh, 2010 .
Several light-stimulating devices have been designed to monitor VEP during surgery, however, due to incompatibility with other surgical devices and unconventional subject positioning required during neurological surgeries, few of them are able to be customized to neurosurgical settings (Kodama et al. , 2010 , Sasaki et al. , 2010 , Chung et al. , 2012 . The SightSaver™ visual stimulator consists of disposable adhesive foam padding designed to contour the periocular region. It contains high intensity light emitting diodes (LED) that are connected with the standard clinical neurophysiology systems used for intraoperative neurophysiological monitoring (IONM) (figure 1).
This pilot study presents a new approach, different from current intraoperative methods of monitoring VEP, relying upon the use of SightSaver™ visual stimulator to determine the comparison of its clinical utility and safety profile for VEP monitoring during prone spine surgeries under TIVA versus balanced general anesthesia.
Methods
The protocol was designed as a pilot, single center, single blinded, prospective, randomized two-arm study. After institutional review board's (Office of Responsible Research Practices) approval, a total of 19 subjects completed the study between October 2014 and May 2015 at The Ohio State University Wexner Medical Center. The clinical trial registry number of this study is NCT02643615.
Eligible subjects that provided voluntary, written informed consent were included in the study. Study inclusion criteria consisted of subjects scheduled for spine surgery that required prone positioning, at least two hours of general anesthesia and intraoperative neurophysiological monitoring, American Society of Anesthesiologists (ASA) physical status I to IV and ages 18 years or older. Exclusion criteria were prisoners, pregnant women or breastfeeding female subjects, and history of contact allergy to foam or plastic devices.
The randomization method used in this study was simple randomization using a random list generator. Consequently, subjects were randomized to receive either TIVA or balanced general anesthesia. Both regimens were standardized as follows: pre-induction medication consisted of the administration of 2-4 mg of midazolam IV. Induction was performed with 1-2 mg/kg of propofol IV, 40-100 mg of lidocaine IV and 50-100 µg of fentanyl IV. For the TIVA group, maintenance was performed with continuous infusion of propofol IV (suggested dose of 100-200 µg/kg/min). The recommended regimen for the balanced general anesthesia group was performed with desflurane (0.5 MAC), 0.05-0.25 µg/kg/min of remifentanil IV, 0.2-0.5 µg/kg/h of dexmedetomidine IV and 20-75 µg/kg/min of propofol IV. Reversal of muscle relaxation was performed with 0.03-0.07 mg/kg of neostigmine IV. PONV prophylaxis was done with the administration of 4-8 mg of ondansetron IV and 4-8 mg of dexamethasone IV.
After anesthesia induction and intubation, the neurophysiology team placed needle electrodes for IONM, including the electrodes for VEP monitoring. A total of 8 electrodes for VEP monitoring were placed subcutaneously as follows: one in the lateral canthus of each eye that recorded early potentials from the retina called the electroretinogram (ERG); the recordings from the visual cortex were performed with three electrodes placed on the scalp 5 cm above mid-occipital (MO) and 5 cm lateral (right occipital (RO) or left occipital (LO)) from the external occipital protuberance (inion). Reference electrodes were placed subcutaneously in the mastoid process bilaterally, with another one placed in the mid-frontal (MF) area, 12 cm. above the nose. The figure 2 illustrates the locations of electrodes for VEP recording.
Following the completion of electrode placement, the SightSaver™ visual stimulator was placed around the orbital area of the subjects (figure 3A-D). The light for the pulse stimulus (flash) was obtained from the six high intensity diodes mounted in the SightSaver™ visual stimulator and applied to each eye individually as single or double stimulus. Therefore, the data presented as a single latency or amplitude corresponds to the results obtained by applying a single flash in each eye and the data presented as double latency or amplitude corresponds to the results obtained by stimulating each eye with two consecutive flashes respectively. Subjects were then positioned prone, and at least two VEP waveforms were recorded to establish baseline following single and double stimuli. Subsequently, two VEP waveforms with single and double stimuli were recorded every 30 minutes during the entire procedure, as per institution's standard of practice.
The single stimulus was obtained with a single pulse of 1.1 Hz, and a train of two pulses of 1.1 Hz with an inter-stimulus interval (ISI) of 50 milliseconds (ms) was used to achieve the double pulse stimulus. Each pulse stimulus lasted for 10 ms at the systems maximum brightness. The use of double stimuli at 50 ms ISI was influenced by a published reliable monitoring methodology "with a new high intensity LED googles and using a double stimuli under general anesthesia" presented at the 3 rd Congress of International Society of Intraoperative Neurophysiology, 2011 (Lladó-Carbó et al. , 2011) . The averages were achieved by summing up 100 responses. The settings for the filter bandpass for VEP and ERG were 20-500 Hz and 10-750 Hz respectively. The latency was measured using the initial prominent negativity (N2) and the amplitude was measured using the peak-to-peak difference of N2 to the following positivity.
VEP waveforms were evaluated using either present baseline -reproducible positivenegative-positive complex of substantial amplitude (≥2 microvolts (µV)) that appeared 100-200 ms after pulse stimulus onset; marginal Baseline -low amplitude (<2 µV) reproducible P100 waveform; or absent baseline -no repeatable response present. Any activity of <0.5 µV was not considered a response. Best derivation for each particular patient was used for monitoring ERG recording and confirming the stimulation. VEP waveforms were analyzed by experienced neurophysiologists in real time. Any significant changes during surgery were analyzed immediately and triggered an alert to the surgeon and anesthesia care providers as needed. VEP alerts were based on a significant change from stable baseline waveform; for example, an absence of VEP waveform ≥50% decreased in amplitude from a stable baseline, or an increase in latency by ≥10%. While, in patients with a marginally monitorable baseline, VEP alerts were generated only when there was a loss of VEP signals.
Subjects' demographics and surgical variables (ASA classification, duration of anesthesia and surgery, estimated blood loss (EBL), hemodynamic variables and length of stay) were collected. Adverse events and serious adverse events related to study procedures were assessed during surgery and 24 hours after surgery.
Statistical Analysis:
Patient demographic and surgical variables were summarized overall and by anesthesia group. Continuous variables were tested between groups using Student's t-tests or Wilcoxon rank-sum tests, where appropriate. Categorical variables were compared between anesthesia groups using chi-squared or Fisher's exact tests, where appropriate. Linear mixed models were fit to assess differences between anesthesia groups in latency and amplitude with single and double stimulus respectively. The models accounted for correlation of repeated within patient measurements over time and across eyes. Interaction terms were assessed in the respective models to determine if there were differences in rates of change of the respective outcomes between anesthesia groups, but were ultimately excluded from the final models. P-values less than 0.05 were considered to be statistically significant. All statistical analyses were conducted using SAS version 9.4 (SAS Institute, Cary, N.C.).
Results
A total of 28 subjects were screened and consented to participate in the study: 7 of them were considered screen failures due to failure meeting inclusion criteria or meeting exclusion criteria, surgery cancelations/re-schedules and in one case, due to lack of versatility and insufficient space between the subjects' head and the Mayfield clamp. Furthermore, 2 subjects were removed from the study after randomization (early termination); one subject had a small periorbital hematoma on the left side after pre-operative electrode placement, and the other subject's VEP data was determined uninterpretable by the neurophysiologist from baseline throughout the entire length of surgery (figure 4). Thus, the data from 19 subjects that completed study procedures were analyzed.
There were no differences in demographic characteristics and surgical variables between the two study groups (Table 1) . The VEP data is presented in figure 5 (A-D) . The study collected VEP information in all subjects (n=19), and evoked potentials were assessed by an experienced neurophysiologist in real time. There was a significant difference in amplitude and latency with single and double stimuli between both groups. On average, the balanced anesthesia group showed 0. . Nevertheless, the median number of intraoperative VEP assessments after baseline among both groups was 6 (collected at 6 times points). Nevertheless, the graphics measuring the amplitude for single and double stimuli in both groups ( figure 5A and 5C) appears to be crossed nearby the 5 th assessment. It is relevant when discussing the results to mention that only 6 subjects (2 TIVA group and 4 Balanced General Anesthesia group) underwent surgery through 150 to 180 time points and they experienced low VEP amplitude throughout surgery. Therefore, we should not elaborate our conclusions based on these limited data. Further studies should address this unforeseen limitation controlling for length of surgery (up to 180 minutes). A typical waveform of a subject randomized to the Balanced General Anesthesia and TIVA groups can be further seen in Figure 6A and Figure 6B respectively.
There was an unexpected event unrelated to study monitoring procedures on one subject; the subject presented a postoperative right eyelid ecchymosis, which was assessed by the anesthesia care provider as a periorbital vessel perforation during electrode needle placement in the lateral canthi, and blood accumulation due to gravity. Furthermore, there were concerns regarding the VEP data received from three subjects enrolled in this study. Two intraoperative VEP alerts were reported by the neurophysiologists in two different subjects. The real-time neurologist assessment concluded that one event was related to technical error and the other event was associated to burst suppression issues due to increased levels of propofol infusion, subjects were allocated into the balanced general anesthesia group and TIVA group respectively. The third subject was randomized to the balanced general anesthesia and the neurologist considered that the VEPs obtained largely unreliable from baseline and throughout the case, consequently subject was considered ineligible for data analysis.
Discussion
VEP monitoring has been reported to be widely variable, both between subjects and within the same subject over time. This variability increases under anesthetic and surgical conditions (Harding et al. , 1990) . The results of this study determined that the use of SightSaver™ visual stimulator was a reliable method of collecting intraoperative VEPs and that the use of TIVA showed higher VEP amplitude and shorter latencies than balanced general anesthesia. This pilot study evaluated the data of 19 subjects that underwent prone position spine surgery. VEP waveforms were recorded every 30 minutes with single and double stimuli during the entire length of surgery.
Due to lower impedance and closer proximity to the source, subdural or subcutaneous electrodes exhibit better signal intensity and resolution than scalp electrodes (Banoub et al. , 2003 , Baig et al. , 2007 . For this reason, subcutaneous electrodes were used for this study. However, the VEP recordings obtained from electrodes placed on the scalp surface are often more user-friendly. No such deficits in functionality were observed in this study (Neuloh, 2010 , Chung et al. , 2012 . Additionally, a flash is the typical way of eliciting an electroretinogram to assess retinal function (Tobimatsu et al. , 2006 , Kamio et al. , 2014 . The SightSaver™ visual stimulator discharged high intensity LED with single and double stimuli on 30-minute intervals. This number of recording incident was far fewer in our study than in the literature (Kamio et al. , 2014) . Other investigators have run VEPs more frequently, for example, Kamio et al. monitored the recordings every 5 minutes (Kamio et al. , 2014) . In addition, diodes can be emitted through several different devices (Harding et al. , 1990 , Kodama et al. , 2010 , Sasaki et al. , 2010 , Kamio et al. , 2014 . The SightSaver™ visual stimulator is a full-face goggle device, but contact lenses, plastic eye-patch-like goggles, and silicone discs can be deployed (Harding et al. , 1990 , Kodama et al. , 2010 , Sasaki et al. , 2010 , Kamio et al. , 2014 . Harding et al. experienced difficulties controlling electronic noise, possibly due to the performance of the contact lenses chosen as a light-emitting device (Harding et al. , 1990) . Kamio et al. adopted the light-stimulating methods of Sasaki et al. using soft silicon discs and reported significant success in VEP recordings (Sasaki et al. , 2010 , Kamio et al. , 2014 .
Previous studies report a larger effect upon VEP waveforms by VIMA and general anesthesia regiments than by TIVA alone (Banoub et al. , 2003 , Kodama et al. , 2010 , Neuloh, 2010 . Watson et al. specifically stated that the problem with balanced general anesthesia is that during the transition from induction with TIVA to maintenance with VIMA adequate depth of sedation is difficult to maintain, due to the varying speed of activation and clearance between anesthetic agents (Watson et al. , 2000) . Banoub et al. and Kodama et al. showed that Nitrous-oxide, an inhaled general anesthetic, tends to interfere with the electrophysiological signal by decreasing amplitudes of the evoked potential waves, which inhibits the ability to interpret the output (Banoub et al. , 2003 , Kodama et al. , 2010 . In addition, Luo et al. reported VEP interference after the use of sodium thiopental and midazolam, both intravenous agents, resulting in the loss of VEP waveform (Luo et al. , 2015) . Banoub et al. also revealed that thiopental decreased amplitude and increased VEP latency (Banoub et al. , 2003) . Other TIVA agents, such as etomidate, produced similar effects in the VEP outputs, but to a lesser degree. Balanced general anesthesia causes more unpredictable outcomes (Banoub et al. , 2003) . Furthermore, our study showed stronger waveforms with TIVA, as concluded by the majority of the literature (Banoub et al. , 2003 , Kodama et al. , 2010 .
Goto et al. used VEP monitoring during a superior hypophyseal artery (SHA) aneurysm clipping and used the loss of visual evoked response as a guideline for predicting postoperative visual disturbances, thus adjusting their surgical procedure accordingly (Goto et al. , 2007) . Their study found that subjects whose VEP waveforms were maintained during the entire length of surgery or lost temporarily and later restored, had no long term visual distress. Conversely, subjects whose intraoperative VEP waveforms were lost and could not be recovered showed postoperative visual disturbance (Goto et al. , 2007) . Furthermore, Harding et al.'s study showed that loss of VEP waveforms for up to three minutes does not indicate permanent visual morbidity, but more than four minutes can increase the risk of postoperative damage (Harding et al. , 1990) . It is unclear whether the use of general anesthesia effected their conclusion (Harding et al. , 1990) . Visual acuity was not measured either before or after the use of SightSaver™ visual stimulator, although no subjects reported a change in visual acuity post-operatively. Two VEP losses were observed in separate subjects in the present study. One loss was due to a technical error. The other VEP loss occurred as a result of burst suppression, with alternating periods of high-voltage electrical brain activity and periods of no brain activity. In one case the VEP data was uninterpretable and hence not used in that procedure. The use of VEP monitoring as a predictor for postoperative visual deterioration is a controversial issue, with evidence concluding a lack of correlation (Bagolini et al. , 1979 , Raudzens, 1980 , Cedzich et al. , 1987 , Wiedemayer et al. , 2003 is nearly equal with that concluding a positive correlation (Aminoff et al. , 1994 , Kamada et al. , 2005 , Mundis et al. , 2009 , Cohen et al. , 2011 . Common issues among literature, either supporting or opposing visual acuity correlation, are part of inherent difficulties of intraoperative VEP monitoring (Bagolini et al. , 1979 , Raudzens, 1980 , Cedzich et al. , 1987 , Aminoff et al. , 1994 , Wiedemayer et al. , 2003 , Kamada et al. , 2005 , Mundis et al. , 2009 , Cohen et al. , 2011 .
Kodama et al. presented a case study involving a 60-year-old woman with an unruptured aneurysm. VEP amplitude was significantly decreased and latency increased during aneurysm occlusion, despite the use of TIVA (Kodama et al. , 2010) . However, wavelengths recovered after the release of occlusion and no damage was observed (Kodama et al. , 2010) . The second subject from this study was a 51 year old who underwent a craniotomy (Kodama et al. , 2010) . The VEP wavelengths in this case did not recover after loss and the subject was blind in the left eye (Kodama et al. , 2010) . These results are consistent with the findings of Goto et al. (Goto et al. , 2007 , Kodama et al. , 2010 . A third case conducted by Kodama et al. produced unique results (Kodama et al. , 2010) . A tumor removal was performed on a 59-year-old male (Kodama et al. , 2010) . During unroofing of the optic canal, the optic nerve was damaged with a diamond drill (Kodama et al. , 2010) . VEP waveforms were maintained, despite anticipated loss, and the subject's visual acuity actually improved post-surgery (Kodama et al. , 2010 , Kamio et al. , 2014 , Luo et al. , 2015 .
Although the SightSaver TM presents many advantages over other VEP devices used in the OR, we encountered some limitations in its use at our institution. The SightSaver TM is attached to the subject's face with adhesive strip. However, the dimensions of the device are not versatile enough to fit properly on some subjects. Therefore, the dark isolation recommended for VEP monitoring was not accomplished every time. At our institution, two types of head support systems are used during prone spine surgeries: the Mayfield Infinity skull clamp ( figure 3B ) and the Proneview® Helmet system ( figure 3C-3D) . In order to ensure proper placement, we had to first attach the SightSaver TM device and then assess the required space to fit the Mayfield clamp. On the other hand, the Proneview® Helmet system consists of a plastic helmet, disposable soft-foam insert and adjustable mirror base attached to the operating table. The foam is contoured to comfortably fit the subject's face with an opening for the eyes, nose, and mouth. Although we did not have to exclude any subjects from the trial for incompatibility between the SightSaver TM and the Proneview® Helmet and Mirror system, it was necessary for us to make modifications to the Proneview®'s foam portion by tearing a small channel in the foam to run the cable from the SightSaver TM device to the IONM system. Additionally, when using the Proneview® Helmet and Mirror system in conjunction with the SightSaver TM , it was impossible for the anesthesia care provider to view and monitor the subject's eyes.
Conclusions
The primary motive and applicability of this study was to determine the safety and efficiency of using the SightSaver™ visual stimulator with TIVA or balanced general anesthesia to collect intraoperative VEP. Our results showed that the SightSaver™ visual stimulator could be a reliable option that simplifies and elicits VEP monitoring methods by protecting subject's eyes against damage or pressure. In addition, our data suggested that TIVA is associated with higher VEP amplitude and shorter latencies than balanced general anesthesia; therefore, TIVA could be the most efficient anesthesia regimen for VEP monitoring. Further studies incorporating a larger variety of surgical procedures including, but not limited to, anterior spinal surgery and cranial surgery should be performed to better prove the efficiency and safety of SightSaver™ visual stimulator. 
